Literature DB >> 26543290

Primary intercavernous lymphoma of the central nervous system.

Arthur Henrique de Aquino Dultra1, Fabio Noro2, Alessandro Severo Alves de Melo3, José Alberto Landeiro4, Edson Marchiori4, Marilene Filgueira do Nascimento5.   

Abstract

Entities:  

Year:  2015        PMID: 26543290      PMCID: PMC4633083          DOI: 10.1590/0100-3984.2014.0078

Source DB:  PubMed          Journal:  Radiol Bras        ISSN: 0100-3984


× No keyword cloud information.
Dear. Editor, A male, 63-year-old, HIV-negative patient was admitted to the hospital with intermittent frontal headache, right facial pain and diplopia for at least two months. Neurological examination revealed both cranial nerves VI paresis and facial pain in the area innervated by the branches V2 and V3 of the right trigeminal nerve. No alteration was observed in the other cranial nerves. The patients presented with normal gait and unaltered muscle strength and balance. Laboratory tests and cerebrospinal fluid puncture revealed normal results. Cranial magnetic resonance imaging (MRI) demonstrated an expansile, intrasellar homogeneous, solid, well delimited lesion, with isosignal on T1- and T2-weighted sequences with a lower enhancement pattern in relation to the hypophysis. The lesion occupied both cavernous sinuses, particularly at right. The way in which the lesion extended suggested the involvement of the intercavernous sinus (Figure 1). The patient was submitted to surgical treatment, with an uneventful postoperative period. Anatomopathological analysis (Figure 2A) demonstrated diffuse non-Hodgkin's B-cell lymphoma. The patient underwent complementary radiotherapy, and successive follow-up with MRI did not demonstrate lesion recurrence in up to five years (Figure 2B).
Figure 1

Pre-resection coronal magnetic resonance imaging T1-weighted sequence, before (A) and after (B) contrast agent injection: homogeneous, solid mass (large arrows) showing intermediate signal intensity in the right cavernous sinus, involving the right internal carotid artery (small arrows), with contralateral extension under the hypophysis. The gland (arrowheads) is superiorly displaced by the mass.

Figure 2

A: Histopathological analysis demonstrates the presence of cells with large nuclei, sometimes with centrally located nucleoli and basophilic cytoplasm. B: Six-month postoperative and post-radiotherapy follow-up. Coronal magnetic resonance imaging T1-weighted sequence: no sign of the lesion is seen neither in the sellar cavity nor in the cavernous sinuses. The hypophysis is slightly reduced in volume (arrow).

Pre-resection coronal magnetic resonance imaging T1-weighted sequence, before (A) and after (B) contrast agent injection: homogeneous, solid mass (large arrows) showing intermediate signal intensity in the right cavernous sinus, involving the right internal carotid artery (small arrows), with contralateral extension under the hypophysis. The gland (arrowheads) is superiorly displaced by the mass. A: Histopathological analysis demonstrates the presence of cells with large nuclei, sometimes with centrally located nucleoli and basophilic cytoplasm. B: Six-month postoperative and post-radiotherapy follow-up. Coronal magnetic resonance imaging T1-weighted sequence: no sign of the lesion is seen neither in the sellar cavity nor in the cavernous sinuses. The hypophysis is slightly reduced in volume (arrow). Central nervous system (CNS) lymphoma is a quite rare neoplasm, affecting most the supratentorial region. In the case of immunocompetent patients, CNS lymphoma manifests as a single, solid lesion, generally without necrosis, with hypo/isosignal on T2- and isosignal on T1-weighted sequences, and intense contrast-enhancement(. Anatomically, cavernous sinuses are irregularly-shaped, trabeculated/compartmentalized venous sinuses located along the lateral aspect of the sella turcica(. Cranial nerves III, IV, V1 and V2 are located within the lateral dural wall, and not within the cavernous sinus(. The two cavernous sinuses communicate with each other via anterior and posterior intercavernous venous plexuses(. Such connections allow for extension of the inflammatory or neoplastic process to the contralateral sinus(. In the case of cavernous sinus lymphoma, considering the proximity to several cranial pairs, cranial nerve lesions may be observed; however this is an uncommon finding(. CNS lymphomas are rarely found, particularly in immunocompetent individuals. In the present case, the unprecedented characteristic is the infra-hypophyseal involvement by dissemination through the intercavernous sinus. Despite its rarity, particularly in immunocompetent individuals, the finding of a solid, homogeneous lesion with isosignal on T1- and T2-weighted sequences in the region of the cavernous sinuses should raise the hypothesis of lymphoma.
  1 in total

1.  [Bilateral cavernous sinus non-Hodgkin's lymphoma as the presenting sign of acquired immunodeficiency syndrome: case report].

Authors:  Alan Kardec Barreira Junior; Frederico Castelo Moura; Mario Luiz Ribeiro Monteiro
Journal:  Arq Bras Oftalmol       Date:  2011 Mar-Apr       Impact factor: 0.872

  1 in total
  4 in total

1.  Burkitt-like lymphoma of the brain mimicking an intraventricular colloid cyst.

Authors:  Rodolfo Mendes Queiroz; Lucas Giansante Abud; Thiago Giansante Abud; Cecília Hissae Miyake; Antonio Carlos Dos Santos
Journal:  Radiol Bras       Date:  2017 Nov-Dec

2.  Nonketotic hyperglycemia with involuntary movements.

Authors:  Tiago Medina Salata; Lívia de Oliveira Antunes; Bruno Niemeyer de Freitas Ribeiro; Rafael Silveira Borges; Diogo Goulart Corrêa
Journal:  Radiol Bras       Date:  2017 Sep-Oct

3.  Imaging of tuberous sclerosis complex: a pictorial review.

Authors:  Felipe Mussi von Ranke; Igor Murad Faria; Gláucia Zanetti; Bruno Hochhegger; Arthur Soares Souza; Edson Marchiori
Journal:  Radiol Bras       Date:  2017 Jan-Feb

Review 4.  Primary marginal zone B-cell lymphoma of the cavernous sinus: a case report and review of the literature.

Authors:  Cheng-Chun Yang; Tai-Yuan Chen; Yu-Kun Tsui; Ching-Chung Ko
Journal:  BMC Med Imaging       Date:  2021-02-12       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.